Signe Holm Nielsen, PhD

Nordic Bioscience
Herlev, Denmark

Head of Dermatology and Spondyloarthritis at Nordic Bioscience.

Disclosure information not submitted.

Presentation(s):

• 2129: Serum Extracellular Matrix Biomarkers Identify Response to Guselkumab in Psoriatic Arthritis; Post-hoc Analysis from a Phase 3, Randomized, Double-blind, Placebo-controlled Study Through 2 Years

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• 2176: Novel Tissue Turnover Blood Markers Are Associated with Pulmonary Arterial Hypertension and NYHA Stages in Patients with Systemic Sclerosis

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time